Navigation Links
Tasker Products Receives USDA Authorization to Begin Commercialization of its Post-Chill Spray Application
Date:6/23/2008

FAIR LAWN, N.J., June 23 /PRNewswire-FirstCall/ -- Tasker Products Corp. (OTC Bulletin Board: TKER), a distributor and marketer of proprietary technology effective in inhibiting pathogenic bacteria, today announced that it has received authorization from the United States Food and Drug Administration ("USDA") to market its post-chill spray application, which will be used immediately after the Chill process in poultry processing plants to further eradicate pathogenic bacteria prior to packaging.

Poultry carcasses are run through a chilling tank to reduce their temperatures to approximately 40 degrees Fahrenheit (or less) to inhibit microscopic spoilage. Chlorine is used in the chilling tank water to destroy bacteria; however, due to the low temperature, solids form reducing the Chlorine's effectiveness in eradicating bacteria. Tasker's post-chill spray using Tasker Blue is highly effective at eradicating bacteria. The Company is also in the process of conducting USDA tests of a post-chill dip and is seeking USDA approval to market its Tasker Blue in the Chiller section.

Tests of Tasker Blue at various intervention points of poultry processing in three separate processing plants indicated that it had a significant and dramatic impact on aerobic plate count ("APC") and E. coli numbers on chicken carcasses to levels not currently attainable with any competing products.

Tasker Blue's ingredients are Generally Recognized as Safe ("GRAS") by the USDA, it does not gas-off (reducing workers' exposure to potentially hazardous fumes), and it poses no organoleptic damage across a broad range of pH concentrations and exposure times.

"We currently market Tasker Blue for use in the scalder, picker and post-picker intervention points. In addition to adding the post-chill spray, we expect to achieve USDA authorization to market Tasker Blue for the chiller section and as a post-chill dip," said Lanny Dacus, Tasker's president and CEO, commenting on the news. "USDA testing policies that were scheduled to go into effect at the end of March, were postponed, which had an impact on our marketing strategy for the scalder application. Although a set date for the new testing policies to go into effect has not been posted, poultry processors are beginning to prepare for the event and, as a result, we are experiencing increased interest in our scalder application."

About Tasker Products

Tasker is a manufacturer, distributor and marketer of eco-chemistry products with various applications that use the pHarlo technology. The pHarlo technology utilizes a highly charged and acidified, yet stable and safe, solution that enables copper sulfate, a compound with bacteriostatic properties, to remain active throughout a wide range of pH values. The Company currently markets Unifresh(R) Footbath, a grooming aid product for dairy cows, Tasker Blue(R), an antibacterial solution for use in processing poultry and Pacific Blue(TM) Seafood Spray, an antibacterial spray for retail seafood counters. Tasker Products Corp. is headquartered in Fair Lawn, New Jersey. To be added to the news distribution list or to present any questions, send an email to tasker@grannusfinancial.com. Additional information about Tasker is also available at http://www.taskerproducts.com.

This release contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statement. Actual future results and trends may differ materially from those made in or suggested by any forward-looking statements due to a variety of factors, including, for example, our ability to obtain new financing and/or generate revenue growth in the near future; our history of losses; our limited experience in the marketing of our products; our ability to compete with other products in our market space; and the risk of unfavorable federal regulation. Consequently, you should not place undue reliance on these forward-looking statements. We discuss these and other risks and uncertainties in greater detail in the filings we make with the Securities and Exchange Commission, including under the section entitled, "Risk Factors" in the Company's Annual Report on Form 10-K, as amended, for the year ended December 31, 2006 and our most recent report on Form 10-Q.

Company and Investor Contact:

Dorren J. Remmen

Chief Financial Officer

Tasker Products Corp.

201-475-7328

DRemmen@TaskerProducts.com


'/>"/>
SOURCE Tasker Products Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. When It comes to Matters of the Heart, Almonds Are a Multi-Tasker
2. Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations
3. Tasker Products Rolls Out Scalder Application at Two New Poultry Processors Facilities
4. China Medicine Maintains Exclusive Rights to Distribute 2,300 Pharmaceutical Products
5. American Dental Hygienists Association and Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. Unveil Honorees of Inaugural HYGIENIST HERO(TM) Recognition Program
6. Natural Nutrition Begins Exports of InterACTIVE Nutrition Brand Products to Pakistan
7. Plaintiffs Lawyer Orders Lead Testing on 3 Popular Herbalife Products; Results Show 728% More Lead Than Allowed by Law Under Proposition 65 Violation
8. Consumers Urged to Avoid Raw Milk and Raw Milk Products
9. Decline in Cigarette Sales Offset by Use of Alternative Products
10. NBTY Announces Agreement to Purchase Leiner Health Products
11. ESA Names James P. Whelan Vice President, Sales & Marketing, Clinical Diagnostic Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... Young Asset Protection, an insurance ... throughout the greater Pittsburgh metropolitan region, is joining forces with the local chapter ... differently-abled children. , Variety the Children’s Charity is a national organization dedicated to ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Hong Kong Polytechnic University (PolyU) launched ... among higher education institutions in Hong Kong to support teaching, learning and research. It ... and quantity of facilities in Hong Kong. , With an area of 620 ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... held the much anticipated Regional Primary Care Spring Symposium on April 1, 2017 ... local medical community, offering physicians and healthcare providers an opportunity to learn about ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Westside Dental ... personalized dental care since 1985. After thirty-two years, Dr. Latner has become one of ... help my numerous clients over the years with all their dental needs,” said Dr. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... reveals good news for older shoulder replacement patients; post-operative recovery just might be ... two groups of patients presenting with osteoarthritis following surgery: 262 patients under 65 ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
Breaking Medicine Technology: